New approach to enhance care for HIV treatment in children and teens

Exploring the impact of resistance testing on HIV treatment in children and adolescents in resource-limited regions like Africa.

Study led by University of Basel researchers showed that supporting patients to take their HIV medication regularly is more important than testing for viral drug resistance.
HIV treatment in children and adolescents is challenging due to treatment failure, but the study found that resistance tests did not significantly improve outcomes.
Adherence to therapy was identified as a crucial factor in achieving successful HIV treatment in young patients.
Limited funding for HIV programs in African countries may be better utilized by focusing on improving treatment adherence rather than widespread resistance testing.
Research results aim to guide resource allocation for HIV programs that address the specific needs of children and adolescents, ultimately improving treatment adherence and outcomes.

Report from NASEM finds disparities in healthcare access for many Americans